Drugmaker Bayer has agreed to settle about 200 of 2,000 cases in which plaintiffs alleged that the use of Trasylol to control bleeding during their heart surgeries caused injuries such as kidney failure and fatal heart problems. One lawyer said he has settled 39 cases for a total of $19.9 million, which would work out to an average settlement of $510,000. Bloomberg reported in August that Bayer had agreed to settle 150 cases for $60 million.
September 14, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Drugmaker Bayer AG has agreed to settle about 200 of 2,000 cases in which plaintiffs alleged that the use of Trasylol to control bleeding during their heart surgeries caused injuries such as kidney failure and fatal heart problems.
One Pennsylvania lawyer, James R. Ronca of Anapol Schwartz Weiss Cohan Feldman & Smalley, said he has settled 39 cases for a total of $19.9 million, which would work out to an average settlement of $510,000.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
